MedTrace Logo

The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine.

NCT02885948 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-12-19

No results posted yet for this study

Summary

This is an investigator led, randomised, double blind, placebo controlled, double arm comparator study.

Conditions

  • Respiratory Depression

Interventions

DRUG

Naloxone

used to block the effects of opioids, especially in overdose

DRUG

Placebo

Placebo, ineffective control arm

Sponsors & Collaborators

  • University College Dublin

    lead OTHER

Principal Investigators

  • Peter Doran, PhD · UCD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02885948 on ClinicalTrials.gov